- In his new role at the FDA, Duke University School of Medicine Vice Chancellor Dr. Robert Califf will have a huge amount of responsibility, including providing executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health and the Center for Tobacco Products.
- Califf's official new title is Deputy Commissioner for Medical Products and Tobacco. Overall, it will be Dr. Califf's responsibility to provide policy direction regarding the FDA's medical product and tobacco priorities.
- Additional responsibilities will include overseeing scientific and regulatory initiatives in personalized medicine, orphan drugs, pediatric science, and the advisory committee system.
Dr. Califf was appointed directly by FDA Commissioner Margaret A. Hamburg. Dr. Califf, who is a recognized Key Opinion Leader in the areas of cardiology, clinical research and economics, will be leaving his current position as vice chancellor of clinical and translational research at Duke University.
His appointment is already spurring rumors that Dr. Califf may become the next Commissioner of the FDA. The current administration will turn over in 2017.